Get Started

NERV

NASD Minerva Neurosciences Inc
Oct 31, 2026 · 4:59 AM ET EOD Market Closed

$2.32 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.32, and at the day’s high of $2.32

YTD change
-42.29%
vs 20-day SMA
-12.53%
vs 200-day SMA
-52.74%

Price ranges

Previous day
$1.96 $2.32
open $2.23 close $2.32
+$0.09 (+4.04%)
Today
$1.96 $2.32
$2.32
Past week
$2.12 $2.65
from $2.40 now $2.32
-$0.08 (-3.33%)
Past month
$2.12 $3.56
from $3.23 now $2.32
-$0.91 (-28.17%)
This year
$1.96 $8.80
from $4.02 now $2.32
-$1.70 (-42.29%)

Price & Performance

-3.75 (-61.78%) / 6M

$1.87$3.47$5.06$6.66May 1Aug 3Oct 30

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 98.1% away from all-time highs of $121.72
  • NERV is down 42% since the beginning of the year
  • NERV is down 43% over the past 12 months
  • NERV is down 28% over the past 1 month
  • 5% of all NERV investors are betting against NERV

NERV reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -44.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.14
Earnings momentum +16.0% Quarterly EPS growth
Quarterly change +16.0%

Valuation

P/E ratio N/A
Enterprise value $173.6M
Beta 1.12

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$75.4M
Debt$71.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $111.5M

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,417.54 +3.19%
JNJ Johnson & Johnson $273.20 -0.73%
ABBV AbbVie, Inc. $294.89 +1.41%
MRK Merck & Co., Inc. $149.52 +2.18%
RHHBY Roche Holding Ltd Sponsored ADR $61.27 +0.82%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.